HAPPEL DAVID (President & CEO) sold 8.7% of their position (65.48K shares) of SAGIMET BIOSCIENCES INC. on the open market
Open‑market sale worth $598.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/23/2025ACC: 0001104659-25-070017
DirectorOfficer· President & CEO
Since Feb 2026
-65.48K
Net shares
Net seller
$598.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
65.48K disposed
Non-Derivative Transactions1
Series A Common Stock
Direct
Shares
−65.48K
Price / share
$9.13
Trade value
$598.12K
% of position
8.7%
7/21/2025
755.20K→689.72K
Total
Net shares
−65.48K
Net value
-$598.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Direct | 7/21/2025 | S · Sale | −65.48K | $9.13 | $598.12K | 8.7% | 755.20K | 689.72K |
| Total | −65.48K | -$598.12K | ||||||
Derivative Transactions0
No derivative transactions reported